Full Press Release Details
Neurosurgery (26%) U.S. Instruments (17%) U.S. Extremities (15%) U.S. Spine Other (19%) International (23%) (%) Shows percentages of 2014 Revenues Integra Prior Segments (% of Total 2014 Revenue) Integra New Revenue Reporting Segments 7 U.S. Neurosurgery (26%) U.S. Instruments (17%) U.S. Extremities (15%) U.S. Spine Other (19%) International (23%) (%) Shows percentages of 2014 Revenues Orthopedics Tissue Technologies (25%) Specialty Surgical Solutions (60%) Spine (15%) Dural Repair Key Franchises: Precision Tools Instruments Tissue Ablation Neuro Critical Care Services and Repair Key Franchises: Regenerative Technologies Lower Extremities Upper Extremities Private Label
Annual Revenue: 2012 2014 3 UNAUDITED ($ in Thousands) Global Segment Revenues: In thousands 2012 2013 2014 Specialty Surgical Solutions 464,169 $ 463,296 $ 554,872 $ U.S. 334,168 332,781 399,538 International 130,001 130,515 155,334 Orthopedics Tissue Technologies 218,972 225,737 235,539 U.S. 174,256 180,664 190,932 International 44,716 45,073 44,607 Spine 147,730 147,181 137,894 U.S. 134,406 129,249 123,570 International 13,324 17,932 14,324 Total Revenue 830,871 $ 836,214 $ 928,305 $ U.S. 642,830 642,694 714,040 International 188,041 193,520 214,265 Quarterly Revenue: 2013 4 UNAUDITED ($ in Thousands) Global Segment Revenues: In thousands Q1 13 Q2 13 Q3 13 Q4 13 2013 Specialty Surgical Solutions 106,433 $ 114,598 $ 120,780 $ 121,485 $ 463,296 $ U.S. 76,161 81,905 87,383 87,332 332,781 International 30,272 32,693 33,397 34,153 130,515 Orthopedics Tissue Technologies 54,193 54,574 56,769 60,201 225,737 U.S. 42,162 43,138 47,793 47,571 180,664 International 12,031 11,436 8,976 12,630 45,073 Spine 36,026 36,375 35,697 39,083 147,181 U.S. 31,696 32,123 31,379 34,051 129,249 International 4,330 4,252 4,318 5,032 17,932 Total Revenue 196,652 $ 205,547 $ 213,246 $ 220,769 $ 836,214 $ U.S. 150,019 157,166 166,555 168,954 642,694 International 46,633 48,381 46,691 51,815 193,520 Quarterly Revenue: 2014 5 UNAUDITED ($ in Thousands) Global Segment Revenues: In thousands Q1 14 Q2 14 Q3 14 Q4 14 2014 Specialty Surgical Solutions 127,195 $ 137,516 $ 137,499 $ 152,662 $ 554,872 $ U.S. 90,447 99,379 101,403 108,309 399,538 International 36,748 38,137 36,096 44,353 155,334 Orthopedics Tissue Technologies 54,589 57,954 58,616 64,380 235,539 U.S. 43,280 47,079 48,056 52,517 190,932 International 11,309 10,875 10,560 11,863 44,607 Spine 33,275 35,881 33,604 35,134 137,894 U.S. 29,655 32,348 30,642 30,925 123,570 International 3,620 3,533 2,962 4,209 14,324 Total Revenue 215,059 $ 231,351 $ 229,719 $ 252,176 $ 928,305 $ U.S. 163,382 178,806 180,101 191,751 714,040 International 51,677 52,545 49,618 60,425 214,265 Integra Historic Revenue Reporting Segments 6 U.S.
The unaudited historical revenue information for these segments is provided in the following slides. This new segment breakout aligns with the way in which we manage the company. Going forward, our commentary and guidance will correspond to these new segments until the completion of the spin off, at which point our business will contain only the Specialty Surgical Solutions and Orthopedics Tissue Technologies segments.
Neurosurgery and U.S. Instruments segments as well as a portion of the International segment. Orthopedic Tissue Technologies is comprised of the former U.S. Extremities segment and a portion of both the U.S. Spine and Other and International segments. The third segment contains the majority of the former U.S. Spine and Other business that will be included in the newly created SeaSpine, which, until the spin off, we will refer to as our Spine segment.
As part of the same announcement, Integra announced that it would realign its existing five business segments into three new segments, each representing global organizations. As of January 1, 2015, the three new segments are called Specialty Surgical Solutions, Orthopedic Tissue Technologies, and Spine. Specialty Surgical Solutions consists of our prior U.S.